Clinical Trial Update: A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis [Phase 3]

View source ↗

Summary

This update outlines a Phase 3 study of QLG1074 in combination with background therapy for active lupus nephritis. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• QLG1074

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Lupus Nephritis | Phase 3 | Status: RECRUITING